Literature DB >> 22269157

Fast and simple LC-MS/MS method for quantifying plasma voriconazole.

Steven Pauwels1, Pieter Vermeersch, Johan Van Eldere, Koen Desmet.   

Abstract

BACKGROUND: An increasing number of publications point to the importance of voriconazole plasma monitoring. Our aim was to develop a fast and simple LC-MS/MS method for the quantification of plasma voriconazole.
METHODS: 20 μL of plasma was extracted by adding a precipitation reagent containing the internal standard (d(3)-voriconazole). Analysis was performed on a Quattro Micro tandem mass spectrometer equipped with an Alliance HPLC 2795 separations module. MRM transitions were m/z 350.0→281.4 for voriconazole and m/z 353.0→284.4 for d(3)-voriconazole. Quantification was done by both linear calibration curves and multiplication of the response ratio by a predefined factor.
RESULTS: A method using protein precipitation as only pretreatment with an analysis time of 2 min was developed. Within- and between-run precision, expressed as coefficient of variation, at 6 concentrations ranged from 2.8% to 11.7%. Accuracy, expressed as a percentage of the theoretically added concentration, ranged from 89.0% to 109.0%. Linearity was demonstrated from 0.06 mg/L (0.17 μM) to 20.0 mg/L (57.3 μM).
CONCLUSIONS: The described method offers a simple and rapid analysis of voriconazole in human plasma for clinical routine. Quantification with a predefined factor permits omitting calibration to each run and thereby reduces workload, costs and turn-around time. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269157     DOI: 10.1016/j.cca.2012.01.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.

Authors:  Kim Vanstraelen; Joost Wauters; Ine Vercammen; Henriette de Loor; Johan Maertens; Katrien Lagrou; Pieter Annaert; Isabel Spriet
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

2.  Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy.

Authors:  Lalit Saini; Jack T Seki; Deepali Kumar; Eshetu G Atenafu; David Ec Cole; Betty Yl Wong; Andrea Božović; Joseph M Brandwein
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

3.  Comparison of LC-MS3 and LC-MRM Method for Quantifying Voriconazole and Its Application in Therapeutic Drug Monitoring of Human Plasma.

Authors:  Wenbo Ren; Lei Yin; Gaixia Zhang; Taiyu Zhai; Jing Huang
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

4.  Performance evaluation of enzyme immunoassay for voriconazole therapeutic drug monitoring with automated clinical chemistry analyzers.

Authors:  Yongbum Jeon; Minje Han; Eun Young Han; Kyunghoon Lee; Junghan Song; Sang Hoon Song
Journal:  Pract Lab Med       Date:  2017-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.